Corteva Launches First Bioinsecticide Goltrevo, Expands Portfolio with Varpelgo to Target Yield-Threatening Pests

Corteva Agriscience has announced the launch of its first bioinsecticide, Goltrevo, alongside the introduction of Varpelgo, marking a strategic expansion in the company’s crop protection portfolio designed to address destructive pest pressures, including corn leafhopper, aphids, whiteflies, and chewing insects.

The dual product release reflects Corteva’s long-term position that biological and synthetic crop protection tools must function in an integrated framework to strengthen farm resilience, improve sustainability, and optimize yields.

According to Corteva, the combination of biological and conventional crop protection solutions can maximize yield potential and return on investment, while supporting broader global imperatives, including climate resilience, sustainability, and food security.

Francisco Javier Garcia, Global Portfolio Manager for Biocontrol at Corteva, emphasized that agricultural protection requires systems-wide approaches rather than isolated product dependency.

“Agriculture is not about one product. We need to take care of crops in a more holistic way,” he noted in an interview with AgFunderNews

Product Overview and Differentiation

Goltrevo is positioned as a broad-spectrum microbial bioinsecticide targeting both sap-feeding pests—such as corn leafhoppers (Dalbulus maidis), whiteflies, and aphids—and chewing insects, including beetles and caterpillars. In contrast, Varpelgo, while not categorized as a biological, is a naturally derived insecticide formulation based on spinosad, originating from the soil bacterium Saccharopolyspora spinosa (also marketed under the brand Qalcova). Varpelgo is indicated for chewing pests in fruits, vegetables, rice, and row crops.

Corn leafhopper infestations represent an escalating threat for maize production, exacerbated by their role as vectors for corn stunt disease, a pathogen associated with severe plant development disruption and substantial yield penalties.

Garcia estimates potential crop losses of up to 70%, particularly as the pest expands beyond late-season corn into earlier planting cycles.

Goltrevo’s differentiation includes extended product shelf-life (24 months versus 12–18 months for comparable solutions) and a reduced likelihood of triggering pest resistance. The company also underscores its multi-crop applicability, including maize, soybean, sugarcane, horticultural crops and pasture systems.

Garcia further highlights the strategic importance of combining biological and synthetic solutions, stating:

“Combining biological with synthetic is critical, key to reducing the risk of resistance, and to get a good level of control.”

Commercialization Timeline and Market Positioning

Goltrevo is expected to enter commercial markets in Brazil in early 2027, pending regulatory approvals, followed by planned expansion into Latin America, North America, and Europe. Varpelgo is expected to launch in Asia-Pacific and Latin America in the early 2030s, subject to field trial and regulatory milestones.

During its latest earnings call, Corteva CEO Chuck Magro projected USD 600 million in biological product revenue in 2025, reinforcing the company’s long-term commercial commitment to the sector.

Biopesticides in the European Context: Policy and Market Outlook

The launch of biologically derived crop protection tools aligns with accelerating regulatory and market momentum in the European Union. The EU has repeatedly emphasized biopesticides as critical instruments for reducing chemical pesticide reliance under the Farm to Fork strategy, which commits to a 50% reduction in chemical pesticide use by 2030.

The European Commission has formally identified microbial pesticides as essential components of Integrated Pest Management (IPM) frameworks and recognizes them for comparatively low toxicity, targeted activity, and lower environmental persistence.

Market analyses reinforce the acceleration of this sector. The EU biopesticides market is forecasted to reach USD 5.1 billion by 2030, growing at an estimated 14% compound annual growth rate (CAGR), driven by regulatory support, consumer demand for residue-free food, and increased resistance to conventional chemistries.

The European Parliamentary Research Service has additionally highlighted that biopesticides can deliver reduced environmental risks, increased biodiversity compatibility, and enhanced suitability for ecologically sensitive agricultural regions, though regulatory bottlenecks and longer authorization timelines remain key barriers to faster adoption.

Corteva’s release of Goltrevo and Varpelgo reflects a broader global transition toward integrated crop protection systems that combine biological and natural origin products with conventional chemistries. This innovation supports mounting evidence and policy direction—particularly in Europe—favoring biologically derived pest control to mitigate resistance development, reduce environmental impact, and enhance agricultural resilience. With commercialization timelines set and market demand increasing, the company positions itself at the forefront of a sector expected to reshape crop protection strategies throughout the coming decade.

In the European Union, biopesticides must undergo centralized active substance approval under Regulation (EC) 1107/2009; however, the selection of a Rapporteur Member State (RMS) significantly impacts evaluation duration, administrative complexity, and overall approval efficiency. While no EU country can bypass regulatory requirements, national authorities differ widely in technical capacity, backlog volumes, digitalization, responsiveness, and experience with biological and microbial plant protection products.

The Netherlands is widely regarded as the most efficient RMS for biopesticides due to its specialized expertise, structured procedural guidance, high acceptance rate for microbial and low-risk actives, and reduced administrative bottlenecks.

Ireland follows as a preferred RMS due to rapid dossier processing, strong regulatory support, efficient communication, and an industry-aligned evaluation framework. Estonia offers notable advantages through fully digitalized governance, low bureaucratic burden, and faster administrative decision timelines, making it an emerging option for expedited submissions, particularly for SMEs and low-risk solutions.

Conversely, jurisdictions such as Germany, France, Italy, and Spain, despite strong scientific evaluation capacities, present longer processing timelines, higher administrative complexity, and recurring backlog challenges. Applicants seeking accelerated EU market entry for biopesticides are increasingly advised to pursue RMS submission through the Netherlands or Ireland, preferably under microbial or low-risk classifications, followed by zonal or mutual recognition procedures to expand authorization into additional EU member states. This strategic pathway significantly reduces regulatory friction and accelerates time-to-market while maintaining full compliance with EU legislative rigor.